Congenital Hearing Loss Clinical Trials in Shanghai, Shanghai Municipality
2 recruitingShanghai, Shanghai Municipality, China
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Clinical Trial of EHT102 Injection in Pediatric Patients With Biallelic hOTOF Mutations
Treatment of Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)
Shanghai Euhearing Therapeutics Co., Ltd30 enrolled1 locationNCT07288580
Recruiting
Not Applicable
A Study of EH002 Gene Therapy for Otoferlin Gene Mutation-mediated Hearing Loss
Hearing Loss, SensorineuralCongenital Hearing LossDFNB9
Yilai Shu24 enrolled2 locationsNCT06722170